cmrouth
Your Child May Qualify for Disability Benefits
The following article was written by Rachel Gaffney. If you would like additional information, you can contact Rachel at rsg@ssd-help.org.
top of page
Search
cmrouth
Jun 2, 20201 min read
Stanford Study on Immune Therapy Treatment of AT/RT
https://scopeblog.stanford.edu/2020/04/30/new-advances-toward-safely-targeting-immune-cells-to-pediatric-brain-tumors/
52 views1 comment
cmrouth
Jan 24, 20201 min read
For Families Facing Malignant Rhabdoid Tumors, Reasons to Hope (repost from DFCI)
Since 2008, Cure ATRT Now, has been funding ATRT targeted research at Dana Farber & St Jude’s hospital. This inspiring story is the...
49 views0 comments
cmrouth
Nov 6, 20171 min read
Epizyme Research Update
We continue to fight to find a cure for ATRT. This is a long & complicated fight but we are making progress, albeit slowly. This is the...
74 views0 comments
cmrouth
Dec 31, 20151 min read
Epizyme launches dosing program
Epizyme announces first patient dosed in global clinical program. Dana Farber Cancer Institute and Cincinnati Children's Hospital are the...
58 views0 comments
cmrouth
Dec 30, 20151 min read
New Research Posted
New research posted to the We Can Help -> Research section of the web site. Pitfalls in Diagnosing AT/RT: Experiences From the European...
22 views0 comments
Cure ATRT Now
Oct 3, 20151 min read
Welcome!
Welcome to the new Cure ATRT Now website. When we started Cure ATRT Now, it was just a few frightened parents frustrated by the scarcity...
46 views0 comments
cmrouth
Sep 28, 20151 min read
Epizyme European Cancer Conference Recap
This presentation contains a lot of information, much of it very technical. The study is not specific to AT/RT, but does include AT/RT...
26 views0 comments
cmrouth
Aug 24, 20151 min read
FDA Accepts Drug in Phase 1 study INI1-Negative Tumors, Including AT/RT
Epizyme, Inc. a clinical stage biopharmaceutical company creating novel epigenetic therapies for patients with cancer, today announced...
24 views0 comments
cmrouth
Aug 6, 20151 min read
What is AT/RT Cancer?
For those just learning about AT/RT, here is an helpful post from the Dana Farber Cancer Institute: http://blog.dana-farber.org/insight/2...
42 views0 comments
cmrouth
Nov 20, 20141 min read
Phase 1 Dose Escalation Shows Promise
Barcelona, Spain, November 20, 2014 – Epizyme, Inc. (NASDAQ: EPZM), a clinical stage biopharmaceutical company creating innovative...
20 views0 comments
bottom of page